TRANSCRANIAL STIMULATION
Treatment of depression, post-traumatic stress disorder (PTSD), normalization of sleep and psycho-emotional state

Transcranial electrical stimulation (TES, tES) is a non-invasive (not associated with penetration through the natural external barriers of the body) and non-drug physiotherapeutic method, in which extremely weak currents of special characteristics are applied through electrodes placed on the patient’s head. This effect selectively activates the brain’s defense mechanisms and causes increased release of endogenous opioid peptides, primarily β-endorphin and serotonin.

Transcranial electrical stimulation is not accompanied by side effects and has a limited range of contraindications. TES therapy is a homeostatic regulator, i.e. normalizer of many disrupted functions. Therefore, the effectiveness of TES is fully evident when there are disruptions in regulating the functions of systems and organs, without affecting the normal ongoing processes.

TES therapy has a wide range of applications, supported by numerous scientific and clinical studies conducted by researchers worldwide. In Russia, research on the clinical application of TES therapy is carried out at the I.P. Pavlov Institute of Physiology of the Russian Academy of Sciences, where more than 30 doctoral and over 120 candidate dissertations on this topic have been defended. Methodological recommendations have been developed and approved, and TES therapy is widely used in medical institutions.

What is the essence of the treatment method?

It is known that very often in mental illnesses (such as depression, post-traumatic stress disorder (PTSD), eating disorders, various other disorders and developmental disorders of the central nervous system), abnormalities are detected during encephalographic studies of the brain. 
The method of treatment consists of exposure to an electromagnetic field of small currents, with which these abnormalities are corrected to return them to normal. 
It is a non-invasive physical therapy procedure that can be combined with the main line of treatment. In contrast to such well-known techniques as TMS and TDCS, an individualized signal file is created for each patient based on the patient’s encephalogram data.

General treatment plan:

  • We do electroencephalography of the patient’s brain.
  • Next, we perform mathematical processing of electroencephalography data and identify abnormal areas.
  • Based on electroencephalography data, we create an individual treatment plan (individual file of transcranial stimulation signal, location of electrodes).
  • Treatment sessions are carried out. The number of treatment sessions varies for each patient, usually 10-15 sessions.

Treatment sessions proceed as follows:

  • The patient sits in a comfortable chair, a cap is placed on the patient’s head, and electrodes are placed.
  • An individual signal for each patient is sent to the electrodes. The signal current is low, comparable to the current from a conventional AA battery.
  • The patient feels a slight tingling and pressure at the points where the electrodes are applied.
  • The session lasts 30 minutes.

In our medical center we perform physiotherapeutic procedures of transcranial electrical stimulation for the following applications:

Improvement of general wellbeing:

  • Normalizes mental and emotional state
  • Improves sleep
  • Enhances productivity
  • Reduces fatigue
  • Alleviates chronic fatigue syndrome
  • Enhances mood
  • Improves overall quality of life

Psychiatry and neurology:

  • Stress relief
  • Treatment of depression
  • Anxiety
  • Obsessive-compulsive disorder (OCD)
  • Post-traumatic stress disorder (PTSD)
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Trigeminal neuralgia
  • Headaches (migraine attacks, post-concussion syndrome, cerebral arachnoiditis, diencephalic syndrome)

Rehabilitation and improvement of cognitive functions:

  • Rehabilitation therapy after stroke
  • Memory improvement
  • Improvement of cognitive functions
  • Alzheimer's disease
  • Dementia due to Parkinson's disease and other types of dementia

Effective pain management:

  • Chronic pain syndromes
  • Postoperative pain
  • Pain associated with chemotherapy and radiation therapy

Dermatology and allergology:

  • Acceleration of reparative regeneration of damages of various origins in all types of tissues, including skin and mucous membrane defects, hepatocyte regeneration, peripheral nerves, and connective tissue.
  • Anti-inflammatory and anti-allergic effects
  • Itching, pruritic dermatoses
  • Neurodermatitis
  • Allergic skin manifestations

Other therapeutic effects of TES therapy:

  • Normalization of autonomic regulation, vascular tone, and blood pressure
  • Stimulation of immunity
  • Inhibition of tumor growth
  • Management of withdrawal syndromes and elimination of post-withdrawal affective disorders in the treatment of alcoholism, drug addiction, elimination of pathological cravings for alcohol
  • Enhancement of the effectiveness of other treatments, including pharmacological ones

CONTRAINDICATIONS TO THE USE OF TES THERAPY

  • Presence of intracranial metallic implants.
  • Presence of implanted pacemakers.
  • Presence of implanted pumps, devices.
  • Presence of hearing aids and cochlear implants.
  • Presence of deep brain stimulation (DBS) devices.
  • Presence of any other metallic medical devices and foreign bodies in the body, except dental implants.
  • Brain tumors
  • Acute infectious lesions of the central nervous system (CNS)
  • Neurosurgical interventions on the brain in the patient’s medical history
  • Presence of focal changes or encephalopathy (tumors, ischemia, hemorrhage, meningitis, encephalitis) associated with the presence of an epileptogenic focus
  • Epilepsy or epileptic seizures in medical history
  • Cases of epilepsy in the patient’s family
  • Situations where seizures may cause serious complications with potential consequences (e.g., cardiovascular decompensation or increased intracranial pressure)
  • Atrial fibrillation
  • Hyperthyroidism (thyrotoxicosis)
  • Hydrocephalus
  • Current pregnancy
  • Patient’s age under 6 years

Disclaimer: Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professionals. Information and statements regarding this product have not been evaluated by the Food and Drug Administration. The products listed on this website are not intended to diagnose, prevent, treat, or cure any disease. see in detail

Bg-popUp_image

Your message has been sent successfully

Our manager will contact you soon.